Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement November 15, 2021 • Valo Health
Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments November 10, 2021 • Valo Health
Valo Health to Participate in Piper Sandler and Goldman Sachs Investor Conferences November 9, 2021 • Valo Health
Valo to Participate at the BofA Securities 2021 Virtual Tech Solutions for Drug Discovery Conference September 16, 2021 • Valo Health
Valo to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit September 9, 2021 • Valo Health
Valo to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence March 18, 2021 • Valo Health
Valo Health Receives $110 Million in Funding From Koch Disruptive Technologies to Close Series B March 9, 2021 • Valo Health
Valo Health to Participate in Barclays and Oppenheimer Healthcare Investor Conferences March 1, 2021 • Valo Health
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference January 11, 2021 • Valo Health